Anthem Biosciences Limited
Kotak Mahindra Life Insurance bought 80,134 shares of Anthem Biosciences Limited for ₹5.97 crore at ₹744.80 apiece in a block deal. This was part of a larger block deal where promoter Aruna Ganesh exited the company by selling a 3.05% stake worth ₹1,275 crore.
A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.
Wholly owned subsidiary of Kotak Mahindra Bank. Crossed Rs 1 lakh crore in AUM in November 2025, the 25th year of operations, with a 19% CAGR since 2010. CIO Radhavi Deshpande joined from Kotak Mahindra Bank's proprietary trading desk in April 2021 and runs a disciplined large and midcap equity book.